STUDY OF ENHANCED ANTI-INFLAMMATORY POTENTIAL OF NIGELLA SATIVA IN TOPICAL NANOFORMULATION

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2018, Vol 10, Issue 7

Abstract

Objective: Formulate a nanocarrier for enhancing the anti-inflammatory activity of thymoquinone (Tq), a major active constituent of Nigella sativa.Methods: Nanoformulation of Tq was developed by low energy emulsification techniques. NanoTqs were pre-screened by different thermodynamic stability tests, followed by in vitro release, zeta potential, viscosity, the transmittance (%), globule size distribution and ex vivo studies. The morphology of the optimized NanoTq was determined by transmission electron microscopy (TEM) which revealed fairly spherical shape and good correlation with particle size distribution study. The formulation used for assessment of the anti-inflammatory potential and permeability enhancement contained mixture of essential oil of Nigella sativa: Capryol 90 (3:7, 10%, v/v), Tween 80 (21.75%, v/v), PEG 400 (7.25%, v/v) and double distilled water (61%, v/v).Results: The in vitro permeation of Tq from optimized formulations was found extremely significant (p<0.001) in comparison to apiTq. The steady state flux (Jss), the permeability coefficient (Kp) and enhancement ratio (Er) of NanoTq gel was determined and compared with apiTq. The comparative anti-inflammatory effects of the optimized formulations NanoTq, apiTq and DicloGel was assessed on the edema in the carrageenan-induced paw model in Wistar rats. Therapeutic potential of NanoTq was found statistically extremely significant (P<0.0001) compared to apiTq and insignificant comparable with standard DicloGel. Storage stability of NanoTq showed insignificant changes in the zeta potential, droplet size and was free from any physical instability.Conclusion: The optimized nano formulation with a lower dose of Tq showed better anti-inflammatory effects, indicating greater absorption capability through the stratum corneum.

Authors and Affiliations

Faisal Obaid Alotaibi, Gulam Mustafa, Alka Ahuja

Keywords

Related Articles

IN SILICO MOLECULAR DOCKING OF XANTHONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITOR AGENTS

Objective: To demonstrate the potential ofdifferent xanthone derivatives as cyclooxygenase-2 (COX-2) inhibitor agents and their selectivity against cycloooxygenase-1 (COX-1) and COX-2 using molecular simulation.Methods:...

COMPARATIVE EVALUATION OF TOTAL PHENOLIC/CAROTENOID CONTENTS, CHLOROGENIC ACID/RUTIN PROFILES, AND ANTIOXIDANT PROPERTIES OF TWO PRANGOS SPECIES (P. UECHTRITZII AND P. PABULARIA)

Objective: The aim of the study was to investigate the antioxidant activities, chlorogenic acid/rutin profiles, and bioactive compounds’ contents of the various extracts from Prangos uechtritzii Boiss. & Hausskn. a...

A COMPARATIVE ANALYSIS OF VITAMIN-C CONCENTRATION IN COMMERCIAL FRUIT JUICES AND FRESH FRUITS OF NEPAL WITH EFFECT OF TEMPERATURE

Objective: It was aimed to determine the best storage temperature for fruits to achieve the highest quality of vitamin-C and to compare vitamin C concentration between commercial fruits juices and fresh fruit juices in b...

EFFECT OF COPPER ON THE GENERATION TIME AND ANTIOXIDANT POTENTIAL OF A NOVEL ISOLATE OF CHLORELLA EMERSONII KJ725233

Objective: At low concentrations copper is an essential micronutrient for algal growth wherein it plays a vital role as an enzyme cofactor for photosynthetic processes but at high concentrations it functions as a toxic h...

A REVIEW OF HEALTH OUTCOME INSTRUMENTS FOR ASTHMATIC CHILDREN & THEIR CAREGIVERS

There are various developed general-as well as disease-or condition-specific health outcome instruments to assess an impact of asthma among asthmatic children but few of these instruments were developed in paired version...

Download PDF file
  • EP ID EP566215
  • DOI 10.22159/ijpps.2018v10i7.22966
  • Views 79
  • Downloads 0

How To Cite

Faisal Obaid Alotaibi, Gulam Mustafa, Alka Ahuja (2018). STUDY OF ENHANCED ANTI-INFLAMMATORY POTENTIAL OF NIGELLA SATIVA IN TOPICAL NANOFORMULATION. International Journal of Pharmacy and Pharmaceutical Sciences, 10(7), 41-51. https://europub.co.uk/articles/-A-566215